Bri-Chem Corp. carries a market capitalization of 7.67M, placing it among publicly traded companies globally. Its enterprise value stands at 20.20M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.67M |
| Enterprise Value | 20.20M |
Bri-Chem Corp. currently has 26.43M shares outstanding.
| Shares Outstanding | 26.43M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Bri-Chem Corp. trades at a trailing price-to-earnings ratio of 4.23. The price-to-sales ratio is 0.09, and the price-to-book ratio stands at 0.34.
| PE Ratio | 4.23 |
| PS Ratio | 0.09 |
| PB Ratio | 0.34 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | 0.64 |
| P/OCF Ratio | 0.67 |
On an enterprise value basis, Bri-Chem Corp. trades at an EV/EBITDA multiple of 4.73 and an EV/FCF ratio of 1.52. The EV/Sales ratio of 0.28 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.31 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.28 |
| EV / EBITDA | 4.73 |
| EV / EBIT | 6.31 |
| EV / FCF | 1.52 |
Bri-Chem Corp. maintains a current ratio of 1.24, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 67.33, indicating elevated leverage, while an interest coverage ratio of 1.75 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.24 |
| Quick Ratio | 0.45 |
| Debt / Equity | 67.33 |
| Debt / EBITDA | 3.27 |
| Interest Coverage | 1.75 |
| Return on Equity (ROE) | 8.29 |
| Return on Assets (ROA) | 3.02 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 4.13 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.03 |
Over the trailing twelve months, Bri-Chem Corp. has paid -452,474.00 in income taxes, reflecting an effective tax rate of 63.11.
| Income Tax | -452,474.00 |
| Effective Tax Rate | 63.11 |
Bri-Chem Corp.'s stock has gained approximately 93.33333% over the past 52 weeks. The 50-day moving average sits at 0.24, while the 200-day moving average is 0.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | 93.33333% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.20 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Bri-Chem Corp. generated 72.26M in revenue and converted that into 1.48M in net income, yielding earnings per share of 0.06. EBITDA reached 4.27M, while operating income came in at 3.20M.
| Revenue | 72.26M |
| Gross Profit | 14.37M |
| Operating Income | 3.20M |
| Pretax Income | 1.02M |
| Net Income | 1.48M |
| EBITDA | 4.27M |
| EBIT | 3.20M |
| Earnings Per Share (EPS) | 0.06 |
Total book value stands at 18.57M, with working capital of 5.38M providing operational flexibility.
| Cash & Cash Equivalents | N/A |
| Total Debt | 13.95M |
| Net Debt | 6.88M |
| Equity (Book Value) | 18.57M |
| Book Value Per Share | 0.70 |
| Working Capital | 5.38M |
Bri-Chem Corp. produced 9.26M in operating cash flow over the past twelve months. After subtracting -542,401.00 in capital expenditures, free cash flow totaled 8.72M - equivalent to 0.33 per share.
| Operating Cash Flow | 9.26M |
| Capital Expenditures | -542,401.00 |
| Free Cash Flow | 8.72M |
| FCF Per Share | 0.33 |
Bri-Chem Corp. operates with a gross margin of 19.89, reflecting its pricing power and cost economics. The operating margin of 4.43 and net profit margin of 2.04 provide insight into operational efficiency.
| Gross Margin | 19.89 |
| Operating Margin | 4.43 |
| Pretax Margin | 1.42 |
| Profit Margin | 2.04 |
| EBITDA Margin | 5.91 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 139.53 |
| FCF Yield | 156.25 |
Bri-Chem Corp. posts an Altman Z-Score of 1.72, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.72 |